Myelodysplastic/Myeloproliferative Neoplasms Clinical Trials
93 clinical trials for Myelodysplastic/Myeloproliferative Neoplasms across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Registry of Older Patients With Cancer — RECRUITING
- Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis — RECRUITING · PHASE1
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer — RECRUITING
- OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study — RECRUITING
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer — ACTIVE_NOT_RECRUITING
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes — COMPLETED · PHASE2
- Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia — COMPLETED · NA
- Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma — COMPLETED
- Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults — OTHER · PHASE2
- Collecting and Storing Blood Samples From Patients With Cancer — WITHDRAWN
- Bone Marrow Transplant in Treating Patients With Hematologic Cancers — COMPLETED · PHASE2
- Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes — TERMINATED · PHASE2
- Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer — TERMINATED · NA
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial — COMPLETED · PHASE3
- Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer — WITHDRAWN · PHASE1
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant — TERMINATED
- Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation — TERMINATED · PHASE2
- Interleukin-2 in Treating Patients With Myelodysplastic Syndrome — COMPLETED · PHASE1
- Cholecalciferol in Treating Patients With Myelodysplastic Syndrome — COMPLETED · PHASE2
- Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes — TERMINATED · PHASE2
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia — COMPLETED · PHASE1
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies — COMPLETED · PHASE1
- Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant — COMPLETED
- Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer — TERMINATED · PHASE2
- Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer — COMPLETED · PHASE1
- Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer — COMPLETED · PHASE3
- Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes — COMPLETED · PHASE1
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant — COMPLETED · PHASE2
- Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases — COMPLETED · NA
- Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant — COMPLETED · PHASE1
- Blood Samples From Patients on a Clinical Trial to CINV During HSCT — TERMINATED
- Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant — TERMINATED · PHASE3
- Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone — COMPLETED
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant — TERMINATED · PHASE2
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder — COMPLETED · PHASE3
- American Ginseng in Treating Patients With Fatigue Caused by Cancer — COMPLETED · PHASE3
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome — TERMINATED · NA
- Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer — COMPLETED · PHASE1
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer — TERMINATED · NA
- Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes — COMPLETED · PHASE2
- Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant — COMPLETED · NA
- Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer — COMPLETED · PHASE1
- T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia — COMPLETED · PHASE2
- Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer — COMPLETED · PHASE2
- Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia — COMPLETED · PHASE2
- Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant — COMPLETED · NA
- Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment — TERMINATED · PHASE1
- A Standardized Nursing Intervention Protocol for HCT Patients — COMPLETED · NA
- Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers — TERMINATED · NA
- Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers — WITHDRAWN
Refine this search